C88.4Extranodal marginal zone B- cell lymphoma of mucosa-associated lymphoid tissue [MALT-lyphoma]
Code usage status
Primary diagnosis
May be used as the primary diagnosis
Apply only when it matches the confirmed diagnosis and the documented clinical record.
Specificity
Complete code in the classification
Use when the diagnosis matches and no exclusion applies.
- Chapter II
- Neoplasms
- Group C00-C97
- Malignant neoplasms U ác tính
- Official Vietnamese name
- U lympho tế bào B vùng rìa ngoài hạch của mô lympho liên quan niêm mạc [MALT-lyphoma]
- Additional WHO coding guidance
- Note: Use additional code (C83.3) if desired, to specify transition to high malignant (diffuse large cell) lymphoma Lymphoma of skin- associated lymphoid tissue (SALT-lymphoma) Lymphoma of bronchial- associated lymphoid tissue (BALT-lymphoma)
Related C88 codes
C88
Malignant immunoproliferativ e diseases
C88.0
Primary diagnosis candidate
Waldenström macroglobulinaemi a
C88.2
Primary diagnosis candidate
Other heavy chain disease
C88.3
Primary diagnosis candidate
Immunoproliferativ e small intestinal disease
C88.7
Primary diagnosis candidate
Other malignant immunoproliferativ e diseases
C88.9
Primary diagnosis candidate
Malignant immunoproliferativ e disease, unspecified
Clinical record checklist
View coding guide →- Confirm that the code matches the final documented diagnosis.
- Use one primary-diagnosis code and record only relevant additional conditions.
- Review Ministry indicators, inclusions, exclusions and notes.
- Do not infer a diagnosis beyond the clinical record.
2026 regulatory basis
Indicators are taken from columns 24–29 of the classification accompanying Circular 06/2026/TT-BYT, cross-referenced with Decision 1849/QĐ-BYT and Official Dispatch 4059/BYT-BH.
